Vanguard Group Inc. lowered its holdings in NovoCure Limited (NASDAQ:NVCR - Free Report) by 0.4% in ...
Global Oncology Leader to Discuss Financial Performance and Future ProspectsRelated Stocks: NVCR,...
BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) will report financial results for the fi...
StockNews.com downgraded NovoCure from a "hold" rating to a "sell" rating in a research report on Sa...